DNA,WVE,PACB Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: REGN SGMO EDIT CRSP NTLA TWST DNLI BEAM FATE CERS

| Held by: VTI IWM VXF THNQ IWN VTWO IBB SCHA PRFZ VHT

Index	RUT	P/E	-	EPS (ttm)	-5.85	Insider Own	27.92%	Shs Outstand	43.82M	Perf Week	-10.22%
Market Cap	592.59M	Forward P/E	-	EPS next Y	-4.35	Insider Trans	-0.15%	Shs Float	40.51M	Perf Month	-24.51%
Enterprise Value	536.78M	PEG	-	EPS next Q	-1.24	Inst Own	58.35%	Short Float	16.56%	Perf Quarter	7.75%
Income	-315.19M	P/S	2.57	EPS this Y	50.15%	Inst Trans	3.33%	Short Ratio	4.03	Perf Half Y	54.95%
Sales	230.81M	P/B	0.86	EPS next Y	17.29%	ROA	-22.07%	Short Interest	6.71M	Perf YTD	1.93%
Book/sh	11.69	P/C	1.22	EPS next 5Y	-	ROE	-43.59%	52W High	16.85 -40.59%	Perf Year	70.24%
Cash/sh	8.19	P/FCF	-	EPS past 3/5Y	39.19% -27.97%	ROIC	-30.26%	52W Low	5.00 100.20%	Perf 3Y	-90.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-10.23% 31.19%	Gross Margin	53.31%	Volatility	6.38% 7.96%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.33	EPS Y/Y TTM	67.53%	Oper. Margin	-133.26%	ATR (14)	0.94	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.41	Sales Y/Y TTM	25.21%	Profit Margin	-136.56%	RSI (14)	38.49	Recom	3.75
Dividend Gr. 3/5Y	- -	Current Ratio	5.41	EPS Q/Q	74.02%	SMA20	-14.70%	Beta	1.50	Target Price	11.33
Payout	-	Debt/Eq	0.70	Sales Q/Q	-11.75%	SMA50	-16.66%	Rel Volume	0.88	Prev Close	10.44
Employees	834	LT Debt/Eq	0.70	Earnings	Aug 07 AMC	SMA200	1.92%	Avg Volume	1.67M	Price	10.01
IPO	Apr 19, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.79% 19.25%	Trades		Volume	1,458,991	Change	-4.12%

Date	Action	Analyst	Rating Change	Price Target Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform	$3.50 → $2.50
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell	$3 → $1.25
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy	$6
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight	$5
May-18-22	Downgrade	BofA Securities	Neutral → Underperform	$3
Mar-02-22	Resumed	Cowen	Outperform	$12
Feb-23-22	Initiated	Goldman	Neutral	$7
Feb-01-22	Initiated	BofA Securities	Neutral	$6
Jan-28-22	Initiated	BofA Securities	Buy	$8
Jan-07-22	Initiated	BTIG Research	Buy	$12
Nov-29-21	Initiated	Jefferies	Buy	$16
Oct-13-21	Initiated	Raymond James	Outperform	$14.50
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy	$14

Show Previous Ratings

Sep-04-25 08:00AM	Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium (Business Wire)
Aug-29-25 04:05PM	Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions (PR Newswire) -13.02%
Aug-20-25 08:01AM	Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry (PR Newswire)
Aug-13-25 09:30AM	Ginkgo Bioworks Holdings, Inc. (DNA) Recently Broke Out Above the 50-Day Moving Average (Zacks) +14.71%
Aug-12-25 08:01AM	Ginkgo Automation Appoints Brian?O'Sullivan as Head of Commercial to Accelerate External Growth (PR Newswire)
03:46AM	Loading…
Aug-08-25 03:46AM	Ginkgo Bioworks Holdings Inc (DNA) Q2 2025 Earnings Call Highlights: Strategic Cost Management ... (GuruFocus.com) -8.69%
Aug-07-25 05:01PM	Ginkgo Bioworks Reports Second Quarter 2025 Financial Results (PR Newswire)
Jul-31-25 09:30AM	Ginkgo Bioworks awarded $4.66M contract by PNNL (TipRanks)
08:01AM	Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation (PR Newswire)
Jul-30-25 09:01AM	Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy (PR Newswire)
Jul-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -6.31%
Jul-17-25 09:01AM	Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors (PR Newswire)
Jul-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know (Zacks)
Jul-10-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why (Zacks) -7.51%
Jul-01-25 06:53AM	Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? (Zacks)
06:15PM	Loading…
Jun-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know (Zacks)
May-21-25 04:05PM	Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer (PR Newswire) -7.38% -7.43%
May-08-25 11:36PM	Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) +6.35%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 06:30PM	Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.79% +14.73%
05:00PM	Ginkgo Bioworks Reports First Quarter 2025 Financial Results (PR Newswire)
May-01-25 07:50AM	Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.56%
Apr-30-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
09:00AM	Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors (PR Newswire)
Apr-29-25 04:00PM	Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation (PR Newswire) -7.98%
Apr-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
Apr-22-25 09:00AM	Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
09:00AM	Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
Apr-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know (Zacks)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +11.23%
09:55AM	Loading…
Apr-10-25 09:55AM	Wall Street Analysts Think Ginkgo Bioworks (DNA) Could Surge 41.59%: Read This Before Placing a Bet (Zacks) +7.67%
09:00AM	Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain (PR Newswire)
Apr-01-25 10:26AM	Is Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy? (Insider Monkey)
09:35AM	Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 Weeks (Zacks)
Mar-27-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) -7.13%
Mar-21-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks) +5.91%
Mar-14-25 09:35AM	After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) (Zacks) +7.89%
Mar-05-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why (Zacks)
Feb-25-25 05:00PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire) -11.47%
Feb-21-25 09:00AM	Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab (PR Newswire) -5.34%
Feb-20-25 08:01AM	Ginkgo Bioworks Partners with HaDEA in Up to 24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care (PR Newswire) -9.86%
Feb-18-25 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation (PR Newswire) -6.52%
Feb-06-25 08:01AM	Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series (PR Newswire) -16.38%
Jan-29-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jan-23-25 08:01AM	Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) (PR Newswire)
Jan-13-25 08:01AM	Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors (PR Newswire) -9.41%
Jan-09-25 11:38AM	Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics (GlobeNewswire)
08:00AM	Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-17-24 12:00PM	All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy (Zacks)
08:11AM	Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program (PR Newswire)
Nov-12-24 05:01PM	Ginkgo Bioworks Reports Third Quarter 2024 Financial Results (PR Newswire)
08:01AM	Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing (PR Newswire)
Nov-05-24 07:00AM	Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation (PR Newswire)
Sep-24-24 07:01AM	NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture (PR Newswire)
Sep-18-24 07:01AM	Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology (PR Newswire) +8.81%
Sep-17-24 08:01AM	Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology (PR Newswire) +9.31%
Sep-04-24 04:30PM	Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement (PR Newswire)
Aug-30-24 07:00AM	Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire) -5.64%
Aug-19-24 07:56AM	Upcoming Stock Splits This Week (August 19 to August 23) Stay Invested (TipRanks) +5.64%
Aug-08-24 05:01PM	Ginkgo Bioworks Reports Second Quarter 2024 Financial Results (PR Newswire) -5.46%
04:00PM	Global Agriculture Biologicals Testing Market Size To Worth USD 5.61 Billion by 2033 CAGR of 7.20% (GlobeNewswire)
Aug-02-24 07:00AM	Ginkgo Bioworks to Hold Special Meeting of Shareholders (PR Newswire) -14.97%
Aug-01-24 07:01AM	Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Presentation (PR Newswire)
Jul-16-24 07:01AM	Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals (Business Wire) +20.65%
Jul-11-24 06:00AM	3 Stocks to Avoid Like the Plague in 2024 (InvestorPlace)
Jul-10-24 04:08PM	3 High-Risk, Sky-High Reward Stocks to Buy for Under $1 (InvestorPlace) +5.35%
06:35AM	Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted (InvestorPlace)
Jul-08-24 07:00AM	7 F-Rated Stocks To Sell in July (InvestorPlace)
Jul-05-24 07:30AM	3 Biotech Stocks to Sell in July Before They Crash & Burn (InvestorPlace) -11.19%
Jun-27-24 03:38PM	Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich (InvestorPlace) +8.91%
Jun-26-24 12:48PM	Perion Layoffs 2024: What to Know About the Latest PERI Job Cuts (InvestorPlace) -11.31%
12:29PM	Ginkgo Bioworks Layoffs Expand to 400 Job Cuts (InvestorPlace)
Jun-24-24 10:52AM	Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears (InvestorPlace) -13.71%
10:31AM	Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts (InvestorPlace)
Jun-20-24 12:31PM	5-Year Fortune Forecast: 3 Penny Stocks Destined for Massive Gains (InvestorPlace)
Jun-19-24 12:00PM	7 Penny Stocks to Sell in June Before They Crash & Burn (InvestorPlace)
Jun-07-24 09:35AM	After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) (Zacks) -6.53%
May-31-24 07:00AM	3 Sorry Biotech Stocks to Sell in May While You Still Can (InvestorPlace) -5.51%
May-17-24 01:58PM	Hedge Fund and Insider Trading News: Paul Marshall, Ray Dalio, Boaz Weinstein, Bill Ackman, Stanley Druckenmiller, Eisler Capital, Archegos Capital Management, Ginkgo Bioworks Holdings Inc (DNA), Visa Inc (VISA), and More (Insider Monkey)
May-15-24 07:01AM	Ginkgo Bioworks to Participate in Two Conferences in May (PR Newswire)
May-14-24 06:00PM	Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan (PR Newswire)
May-13-24 04:05PM	Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE (PR Newswire) +10.49%
May-10-24 07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -17.29%
May-09-24 05:45PM	Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Ginkgo Bioworks Reports First Quarter 2024 Financial Results (PR Newswire)
May-08-24 01:46PM	3 Meme Stocks to Sell in May Before They Crash & Burn (InvestorPlace)
May-07-24 12:31PM	Want $10,000? Invest $1,000 in These 3 Penny Stocks Now (InvestorPlace) -5.48%
11:43AM	16 Best US Stocks To Invest In Under $10 (Insider Monkey)
07:01AM	GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener (PR Newswire)
May-06-24 07:01AM	Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting (PR Newswire)
May-02-24 07:00AM	Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation (PR Newswire)
Apr-29-24 05:24PM	Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock? (InvestorPlace) +15.08% -9.97%
04:01PM	Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors (PR Newswire)
Apr-25-24 08:01AM	AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029 (PR Newswire) -8.05%
Apr-16-24 07:02AM	Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products (PR Newswire)
Apr-11-24 07:01AM	Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces 'Lab Data as a Service' (PR Newswire) -6.25%
07:01AM	Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets (PR Newswire)
Apr-10-24 07:02AM	Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain (PR Newswire)
07:01AM	Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks (PR Newswire)
Apr-08-24 07:00AM	IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service (PR Newswire)

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HENRY CHRISTIAN O	Director	Sep 09 '25	Sale	11.06	10,000	110,600	24,310	Sep 10 04:06 PM
HENRY CHRISTIAN O	Director	Sep 08 '25	Sale	10.92	10,000	109,200	34,310	Sep 10 04:06 PM
Che Austin	Officer	Sep 10 '25	Proposed Sale	10.78	2,200	23,716		Sep 10 09:51 AM
HENRY CHRISTIAN O	Director	Sep 09 '25	Proposed Sale	11.06	10,000	110,600		Sep 09 11:06 AM
HENRY CHRISTIAN O	Director	Sep 08 '25	Proposed Sale	10.92	10,000	109,209		Sep 08 12:19 PM
Coen Steven P.	See remarks	Aug 22 '25	Sale	12.40	310	3,843	11,112	Aug 26 04:10 PM
Che Austin	Officer	Aug 06 '25	Proposed Sale	14.10	2,200	31,020		Aug 06 09:48 AM
Coen Steven P.	See remarks	Jul 17 '25	Sale	9.84	1,084	10,669	10,679	Jul 21 04:28 PM
Dmytruk Mark E.	Officer	Jul 17 '25	Proposed Sale	9.84	640	6,299		Jul 17 05:20 PM
Che Austin	Officer	Jul 09 '25	Proposed Sale	11.18	2,200	24,596		Jul 09 12:07 PM
Che Austin	Officer	Jun 23 '25	Proposed Sale	8.43	99	835		Jun 23 09:54 AM
Che Austin	Officer	Jun 20 '25	Proposed Sale	8.66	99	857		Jun 20 09:50 AM
Che Austin	Officer	Jun 18 '25	Proposed Sale	8.46	99	838		Jun 18 09:41 AM
Che Austin	Officer	Jun 17 '25	Proposed Sale	9.06	99	897		Jun 17 11:58 AM
Che Austin	Officer	Jun 16 '25	Proposed Sale	9.04	99	895		Jun 16 10:21 AM
Che Austin	Officer	Jun 13 '25	Proposed Sale	8.92	99	883		Jun 13 10:04 AM
Che Austin	Officer	Jun 12 '25	Proposed Sale	9.51	99	941		Jun 12 09:45 AM
Che Austin	Officer	Jun 11 '25	Proposed Sale	8.93	99	884		Jun 11 09:58 AM
Che Austin	Officer	Jun 10 '25	Proposed Sale	7.99	99	791		Jun 10 10:07 AM
Che Austin	Officer	Jun 09 '25	Proposed Sale	7.75	99	767		Jun 09 10:01 AM
Che Austin	Officer	Jun 06 '25	Proposed Sale	7.32	99	725		Jun 06 10:05 AM
Che Austin	Officer	Jun 05 '25	Proposed Sale	7.60	99	752		Jun 05 10:20 AM
Che Austin	Officer	Jun 04 '25	Proposed Sale	7.55	99	747		Jun 04 10:26 AM
Che Austin	Officer	Jun 03 '25	Proposed Sale	7.27	99	720		Jun 03 10:08 AM
Che Austin	Officer	Jun 02 '25	Proposed Sale	6.97	99	690		Jun 02 09:47 AM
Che Austin	Officer	May 30 '25	Proposed Sale	7.12	99	705		May 30 09:40 AM
Che Austin	Officer	May 29 '25	Proposed Sale	7.62	99	754		May 29 09:37 AM
Che Austin	Officer	May 28 '25	Proposed Sale	6.96	99	689		May 28 09:36 AM
Che Austin	Officer	May 27 '25	Proposed Sale	7.20	99	713		May 27 11:00 AM
Che Austin	Officer	May 23 '25	Proposed Sale	6.75	99	668		May 23 09:55 AM
Coen Steven P.	See remarks	May 21 '25	Sale	7.58	346	2,624	9,216	May 22 04:06 PM
Dmytruk Mark E.	See remarks	May 21 '25	Sale	7.58	706	5,355	46,226	May 22 04:05 PM
Che Austin	Officer	May 22 '25	Proposed Sale	7.15	99	708		May 22 09:54 AM
Dmytruk Mark E.	Officer	May 21 '25	Proposed Sale	7.58	706	5,355		May 21 04:11 PM
Che Austin	Officer	May 21 '25	Proposed Sale	7.86	99	778		May 21 09:54 AM
Che Austin	Officer	May 20 '25	Proposed Sale	8.10	99	802		May 20 09:41 AM
Che Austin	Officer	May 19 '25	Proposed Sale	7.70	99	762		May 19 11:03 AM
Che Austin	Officer	May 16 '25	Proposed Sale	7.72	99	764		May 16 09:40 AM
Che Austin	Officer	May 15 '25	Proposed Sale	7.73	99	765		May 15 10:57 AM
Che Austin	Officer	May 14 '25	Proposed Sale	8.01	99	793		May 14 10:18 AM
Che Austin	Officer	May 13 '25	Proposed Sale	8.40	99	832		May 13 09:48 AM
Che Austin	Officer	May 12 '25	Proposed Sale	8.16	99	808		May 12 09:44 AM
Che Austin	Officer	May 09 '25	Proposed Sale	7.97	99	789		May 09 09:40 AM
Che Austin	Officer	May 08 '25	Proposed Sale	7.49	99	742		May 08 09:46 AM
Che Austin	Officer	May 07 '25	Proposed Sale	6.83	99	676		May 07 09:52 AM
Che Austin	Officer	May 06 '25	Proposed Sale	6.75	99	668		May 06 09:41 AM
Che Austin	Officer	May 05 '25	Proposed Sale	7.00	99	693		May 05 09:58 AM
Che Austin	Officer	May 02 '25	Proposed Sale	7.15	99	708		May 02 09:41 AM
Che Austin	Officer	May 01 '25	Proposed Sale	7.47	99	740		May 01 10:07 AM
Che Austin	Officer	Apr 30 '25	Proposed Sale	7.14	99	707		Apr 30 09:59 AM
Che Austin	Officer	Apr 29 '25	Proposed Sale	7.94	99	786		Apr 29 09:51 AM
Che Austin	Officer	Apr 28 '25	Proposed Sale	7.95	99	787		Apr 28 09:50 AM
Che Austin	Officer	Apr 25 '25	Proposed Sale	7.92	99	784		Apr 25 09:49 AM
Che Austin	Officer	Apr 24 '25	Proposed Sale	7.68	99	760		Apr 24 09:47 AM
Coen Steven P.	See remarks	Apr 21 '25	Sale	7.28	997	7,261	8,819	Apr 23 05:03 PM
Dmytruk Mark E.	See remarks	Apr 21 '25	Sale	7.28	1,244	9,060	45,453	Apr 23 05:00 PM
Che Austin	Officer	Apr 23 '25	Proposed Sale	8.05	99	797		Apr 23 09:54 AM
Che Austin	Officer	Apr 22 '25	Proposed Sale	7.49	99	742		Apr 22 09:48 AM
Dmytruk Mark E.	Officer	Apr 21 '25	Proposed Sale	7.28	1,244	9,060		Apr 21 04:16 PM
Che Austin	Officer	Apr 21 '25	Proposed Sale	7.50	99	742		Apr 21 09:51 AM
Che Austin	Officer	Apr 17 '25	Proposed Sale	8.09	99	801		Apr 17 09:49 AM
Che Austin	Officer	Apr 16 '25	Proposed Sale	8.17	99	809		Apr 16 09:49 AM
Che Austin	Officer	Apr 15 '25	Proposed Sale	8.41	99	833		Apr 15 09:47 AM
Che Austin	Officer	Apr 14 '25	Proposed Sale	8.37	99	829		Apr 14 10:10 AM
Che Austin	Officer	Apr 11 '25	Proposed Sale	7.50	99	742		Apr 11 09:42 AM
Che Austin	Officer	Apr 10 '25	Proposed Sale	6.54	99	647		Apr 10 09:45 AM
Che Austin	Officer	Apr 09 '25	Proposed Sale	5.73	99	567		Apr 09 09:47 AM
Che Austin	Officer	Apr 08 '25	Proposed Sale	6.80	99	673		Apr 08 09:38 AM
Che Austin	Officer	Apr 07 '25	Proposed Sale	5.16	99	511		Apr 07 10:36 AM
Che Austin	Officer	Apr 04 '25	Proposed Sale	5.50	99	544		Apr 04 09:40 AM
Che Austin	Officer	Apr 03 '25	Proposed Sale	5.50	99	544		Apr 03 10:17 AM
Che Austin	Officer	Apr 02 '25	Proposed Sale	5.45	99	540		Apr 02 10:10 AM
Che Austin	Officer	Apr 01 '25	Proposed Sale	5.69	99	563		Apr 01 10:57 AM
Che Austin	Officer	Mar 31 '25	Proposed Sale	5.73	99	567		Mar 31 09:58 AM
Che Austin	Officer	Mar 28 '25	Proposed Sale	6.54	99	647		Mar 28 10:57 AM
Che Austin	Officer	Mar 27 '25	Proposed Sale	6.63	99	656		Mar 27 09:36 AM
Che Austin	Officer	Mar 26 '25	Proposed Sale	7.11	99	704		Mar 26 09:49 AM
Che Austin	Officer	Mar 25 '25	Proposed Sale	7.75	99	767		Mar 25 09:51 AM
Che Austin	Officer	Mar 24 '25	Proposed Sale	7.53	99	745		Mar 24 09:53 AM
Che Austin	Officer	Mar 21 '25	Proposed Sale	7.00	99	693		Mar 21 09:44 AM
Che Austin	Officer	Mar 20 '25	Proposed Sale	7.40	99	733		Mar 20 09:42 AM
Che Austin	Officer	Mar 19 '25	Proposed Sale	7.27	99	720		Mar 19 09:42 AM
Che Austin	Officer	Mar 18 '25	Proposed Sale	7.88	99	780		Mar 18 09:51 AM
Che Austin	Officer	Mar 17 '25	Proposed Sale	7.02	99	695		Mar 17 10:22 AM
Che Austin	Officer	Mar 14 '25	Proposed Sale	6.76	99	669		Mar 14 09:40 AM
Che Austin	Officer	Mar 13 '25	Proposed Sale	6.77	99	670		Mar 13 09:46 AM
Che Austin	Officer	Mar 12 '25	Proposed Sale	7.21	99	714		Mar 12 09:47 AM
Che Austin	Officer	Mar 11 '25	Proposed Sale	6.98	99	691		Mar 11 12:03 PM
Che Austin	Officer	Mar 10 '25	Proposed Sale	7.32	99	725		Mar 10 09:46 AM
Che Austin	Officer	Mar 07 '25	Proposed Sale	7.75	99	767		Mar 07 09:43 AM
Coen Steven P.	See remarks	Mar 04 '25	Sale	7.72	395	3,051	8,012	Mar 06 05:06 PM
Dmytruk Mark E.	See remarks	Mar 04 '25	Sale	7.72	790	6,103	34,652	Mar 06 05:00 PM
Che Austin	Officer	Mar 06 '25	Proposed Sale	7.97	99	789		Mar 06 12:03 PM
Che Austin	Officer	Mar 05 '25	Proposed Sale	8.33	99	825		Mar 05 09:50 AM
Dmytruk Mark E.	Officer	Mar 04 '25	Proposed Sale	7.73	790	6,103		Mar 04 03:34 PM
Che Austin	Officer	Mar 04 '25	Proposed Sale	7.75	99	767		Mar 04 10:01 AM
Che Austin	Officer	Mar 03 '25	Proposed Sale	8.45	99	837		Mar 03 11:00 AM
Che Austin	Officer	Feb 28 '25	Proposed Sale	8.37	99	829		Feb 28 09:36 AM
Che Austin	Officer	Feb 27 '25	Proposed Sale	9.26	99	917		Feb 27 10:14 AM
Che Austin	Officer	Feb 26 '25	Proposed Sale	9.00	99	891		Feb 26 09:47 AM

WVE Wave Life Sciences Ltd daily Stock Chart

Peers: IONS ALNY SRPT ARWR MRNA NBIX VRTX BIIB QURE EDIT

| Held by: IWM VXF IWO IBB VTWO SCHA VHT XPH LFSC IHE

Index	RUT	P/E	-	EPS (ttm)	-0.89	Insider Own	20.18%	Shs Outstand	155.67M	Perf Week	-15.92%
Market Cap	1.11B	Forward P/E	-	EPS next Y	-1.18	Insider Trans	-0.94%	Shs Float	127.03M	Perf Month	-20.43%
Enterprise Value	930.31M	PEG	-	EPS next Q	-0.26	Inst Own	83.54%	Short Float	13.63%	Perf Quarter	-3.19%
Income	-129.87M	P/S	11.81	EPS this Y	-64.49%	Inst Trans	8.84%	Short Ratio	9.84	Perf Half Y	-32.13%
Sales	93.95M	P/B	7.79	EPS next Y	-2.35%	ROA	-56.32%	Short Interest	17.32M	Perf YTD	-43.65%
Book/sh	0.89	P/C	5.32	EPS next 5Y	-12.53%	ROE	-171.41%	52W High	16.74 -58.35%	Perf Year	16.95%
Cash/sh	1.31	P/FCF	-	EPS past 3/5Y	33.25% 34.27%	ROIC	-80.81%	52W Low	5.28 32.01%	Perf 3Y	126.30%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	38.28% 46.62%	Gross Margin	90.77%	Volatility	5.97% 6.21%	Perf 5Y	-42.25%
Dividend TTM	-	EV/Sales	9.90	EPS Y/Y TTM	-51.76%	Oper. Margin	-152.76%	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.56	Sales Y/Y TTM	-14.98%	Profit Margin	-138.24%	RSI (14)	29.71	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	2.56	EPS Q/Q	-21.09%	SMA20	-21.93%	Beta	-1.35	Target Price	19.80
Payout	-	Debt/Eq	0.15	Sales Q/Q	-55.82%	SMA50	-17.36%	Rel Volume	1.05	Prev Close	7.16
Employees	288	LT Debt/Eq	0.09	Earnings	Jul 30 BMO	SMA200	-25.31%	Avg Volume	1.76M	Price	6.97
IPO	Nov 11, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.79% -34.10%	Trades		Volume	1,852,228	Change	-2.65%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-04-25	Initiated	Canaccord Genuity	Buy	$19
Jul-28-25	Initiated	Oppenheimer	Outperform	$24
Jul-16-25	Initiated	Citigroup	Buy	$16
Jun-11-25	Resumed	Raymond James	Outperform	$14
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight	$10
Apr-08-25	Initiated	Wedbush	Outperform	$18
Feb-25-25	Initiated	Jefferies	Buy	$26
Oct-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$22
Sep-27-24	Resumed	JP Morgan	Overweight	$10 → $13
Sep-19-24	Initiated	B. Riley Securities	Buy	$11
Sep-09-24	Initiated	JP Morgan	Overweight	$10
May-15-24	Initiated	Wells Fargo	Overweight	$11
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform	$5 → $12
Jul-05-23	Initiated	Raymond James	Outperform	$7
May-24-23	Downgrade	Jefferies	Buy → Hold	$7 → $5
Dec-15-20	Resumed	H.C. Wainwright	Buy	$20
Oct-23-20	Initiated	RBC Capital Mkts	Sector Perform	$13
Dec-31-19	Downgrade	SVB Leerink	Outperform → Mkt Perform	$33 → $10
Nov-01-19	Initiated	Guggenheim	Buy	$43
Jul-15-19	Initiated	Cowen	Market Perform

Show Previous Ratings

Sep-05-25 09:30AM	B. Riley aggressive buyer of Wave Life on material disconnect (TipRanks)
Sep-03-25 07:48AM	Wave shares sink on new study results for RNA editing drug (BioPharma Dive) -16.84%
07:30AM	Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Aug-29-25 05:09AM	Wave Life Sciences Ltd. (WVE) Gains Momentum With Multiple RNA Wins (Insider Monkey)
Aug-03-25 06:25AM	Oppenheimer Predicts Up to 590% Rally for These 2 Strong Buy Stocks (TipRanks)
05:01AM	Loading…
Jul-31-25 05:01AM	WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Call Highlights: Progress in RNA Editing Amid ... (GuruFocus.com)
Jul-30-25 09:00AM	Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:58AM	Wave Life Sciences: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
Jul-29-25 09:48AM	WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-24-25 10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-23-25 08:30AM	Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 (GlobeNewswire) +7.94%
Jul-15-25 08:59AM	Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions (Insider Monkey)
Jul-11-25 11:27AM	Leerink Partners Reiterates a Buy Rating on Wave Life Sciences (WVE), Keeps the PT at $24 (Insider Monkey)
Jul-03-25 09:18AM	H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release (Insider Monkey)
04:01PM	Loading…
Jun-20-25 04:01PM	Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions (GlobeNewswire) +5.94%
Jun-11-25 09:45AM	Raymond James bullish on biotech firms on favorable valuation (Investing.com)
May-29-25 08:30AM	Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference (GlobeNewswire)
May-28-25 08:00AM	Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer (GlobeNewswire)
May-13-25 08:45AM	Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now? (Insider Monkey)
May-09-25 03:18AM	WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ... (GuruFocus.com)
May-08-25 08:50AM	Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:45AM	Wave Life Sciences: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
May-07-25 12:45PM	Wave Life Sciences Q1 2025 Earnings Preview (Seeking Alpha)
10:25AM	WAVE Life Sciences Ltd (WVE) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
08:30AM	Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-06-25 05:35PM	Myriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -17.08%
May-01-25 10:01AM	Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:30AM	Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025 (GlobeNewswire)
09:03AM	Loading…
Mar-31-25 09:03AM	The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics (Zacks) -6.26%
Mar-28-25 09:39AM	Promising Genomics & Synthetic Biology Stocks to Consider in 2025 (Zacks)
09:00AM	RNA Biotechs: Current State And Outlook (Seeking Alpha)
Mar-27-25 03:54PM	Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531 (SeekingAlpha) -10.08%
09:05AM	Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531 (Clinical Trials Arena)
05:35AM	Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar? (Zacks)
Mar-26-25 07:30AM	Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 (GlobeNewswire) +6.14%
07:25AM	Wave to seek approval of Duchenne drug after mid-stage study data (BioPharma Dive)
Mar-20-25 09:28AM	Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains? (Zacks)
Mar-05-25 02:05AM	WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Clinical ... (GuruFocus.com) -5.88%
Mar-04-25 07:52AM	Wave Life Sciences: Q4 Earnings Snapshot (Associated Press Finance) +11.74%
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (GlobeNewswire)
Mar-03-25 07:09AM	Earnings To Watch: WAVE Life Sciences Ltd (WVE) Reports Q4 2024 Result (GuruFocus.com)
Feb-25-25 08:30AM	Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 (GlobeNewswire)
Feb-19-25 09:43AM	What Makes Wave Life Sciences Ltd. (WVE) an Investment Bet? (Insider Monkey)
Feb-06-25 08:30AM	Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity (GlobeNewswire)
Jan-13-25 04:31PM	Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential? (Insider Monkey)
09:00AM	Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation (GlobeNewswire)
Jan-09-25 05:10PM	Is Wave Life Sciences Ltd. (WVE) the Best Growth Stock to Buy Now Under $25? (Insider Monkey)
Dec-23-24 08:30AM	Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity (GlobeNewswire)
Dec-16-24 08:30AM	Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-26-24 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-15-24 08:30AM	Wave Life Sciences to Present at Jefferies London Healthcare Conference (GlobeNewswire) -8.87%
Nov-13-24 02:08AM	WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
Nov-12-24 09:00AM	Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:58AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Nov-11-24 07:08AM	WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Nov-05-24 10:00AM	Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Nov-04-24 04:05PM	Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 (GlobeNewswire)
Oct-30-24 04:45PM	Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs (GlobeNewswire)
Oct-29-24 05:47PM	How to play biotech stocks: Insmed and Wave Life Sciences (Yahoo Finance Video)
Oct-28-24 09:55AM	Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know (Zacks)
Oct-24-24 05:53AM	1 Brand-New Big Reason to Buy This Biotech Stock Right Now (Motley Fool)
Oct-23-24 12:00PM	What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now? (Zacks)
Oct-21-24 04:15PM	Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. (Investor's Business Daily)
Oct-17-24 10:56AM	Wave Life Sciences Shares Surge After RNA Editing Discovery (GuruFocus.com)
07:33AM	Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last? (Zacks)
Oct-16-24 04:20PM	Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed. (Investor's Business Daily) +74.07%
04:13PM	RNA-Editing Stocks Soar by Record on Wave Lifes Trial Data (Bloomberg)
01:16PM	Wave Life Sciences Stock Climbs on RNA Editing Progress (The Wall Street Journal)
08:44AM	Wave Life Sciences (WVE): Advancing Gene Therapy for Duchenne Muscular Dystrophy (Insider Monkey)
08:30AM	Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
08:25AM	Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024 (GlobeNewswire)
08:15AM	Wave sees RNA editing validation in early trial results (BioPharma Dive)
Oct-11-24 11:56AM	GSK Bought More Shares of Biotech Wave Life Sciences (Barrons.com)
09:55AM	How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71% (Zacks)
Oct-09-24 05:36PM	WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... (GuruFocus.com) +5.12%
Oct-03-24 08:15AM	Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics (Motley Fool)
Oct-01-24 09:20AM	Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Sep-30-24 08:30AM	Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-25-24 09:14PM	Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +10.01% -10.99%
06:32AM	Waves stock swells as it eyes approval following Phase II DMD victory (Clinical Trials Arena)
Sep-24-24 04:01PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +53.37%
11:19AM	Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug (Benzinga)
07:30AM	Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping (GlobeNewswire)
Aug-24-24 01:17AM	Insider Selling: President and CEO Paul Bolno Sells 48,366 Shares of WAVE Life Sciences Ltd (WVE) (GuruFocus.com)
Aug-12-24 08:30AM	Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy (GlobeNewswire)
Aug-08-24 08:45AM	Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:47AM	Wave Life Sciences: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-24 08:30AM	Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024 (GlobeNewswire) -6.81%
Jun-25-24 07:30AM	Wave, with new data, plots path forward for Huntingtons drug (BioPharma Dive) -8.45%
07:30AM	Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington's Disease (GlobeNewswire)
Jun-12-24 08:30AM	Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing (GlobeNewswire)
May-30-24 08:30AM	Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-24 07:16AM	Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target (MT Newswires)
May-10-24 04:53PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:39PM	WAVE Life Sciences Reports First Quarter 2024 Financial Results (GuruFocus.com)
May-09-24 07:45AM	Wave Life Sciences: Q1 Earnings Snapshot (Associated Press Finance)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Verdine Gregory L.	Director	Aug 22 '25	Sale	10.00	10,000	100,000	285,217	Aug 26 09:40 PM
BOLNO PAUL	President and CEO	Aug 22 '25	Sale	10.10	217,351	2,194,810	121,000	Aug 26 09:40 PM
PAUL BOLNO	Director	Aug 22 '25	Proposed Sale	9.76	217,351	2,121,346		Aug 22 04:41 PM
GREGORY VERDINE	Director	Aug 22 '25	Proposed Sale	9.76	25,000	244,000		Aug 22 04:38 PM
Tan Aik Na	Director	Aug 15 '25	Option Exercise	9.13	21,000	191,730	61,388	Aug 19 08:00 PM
Tan Aik Na	Director	Aug 15 '25	Sale	9.25	21,000	194,250	40,388	Aug 19 08:00 PM
AIK NA TAN	Director	Aug 15 '25	Proposed Sale	9.25	21,000	194,250		Aug 15 04:59 PM
HENRY CHRISTIAN O	Director	Aug 13 '25	Sale	8.81	9,670	85,193	29,645	Aug 13 08:00 PM
Christian Henry	Director	Aug 13 '25	Proposed Sale	7.70	9,670	74,459		Aug 13 04:02 PM
TAKANASHI KEN	Director	Aug 05 '25	Sale	8.75	4,872	42,630	5,716,303	Aug 07 08:00 PM
Tan Aik Na	Director	Aug 05 '25	Sale	8.75	1,127	9,861	14,988	Aug 07 08:00 PM
Verdine Gregory L.	Director	Jun 13 '25	Sale	6.95	30,000	208,500	282,517	Jun 13 08:00 PM
GREGORY VERDINE	Director	Jun 13 '25	Proposed Sale	7.20	30,000	216,000		Jun 13 04:44 PM
HENRY CHRISTIAN O	Director	Mar 20 '25	Option Exercise	9.13	10,500	95,865	26,615	Mar 21 09:00 PM
HENRY CHRISTIAN O	Director	Mar 20 '25	Sale	9.77	10,500	102,574	16,115	Mar 21 09:00 PM
Christian Henry	Director	Mar 20 '25	Proposed Sale	9.77	10,500	102,579		Mar 20 04:03 PM
BOLNO PAUL	President and CEO	Mar 07 '25	Option Exercise	2.48	169,025	419,182	507,376	Mar 07 09:05 PM
BOLNO PAUL	President and CEO	Mar 07 '25	Sale	9.57	169,025	1,617,569	338,351	Mar 07 09:05 PM
Verdine Gregory L.	Director	Mar 07 '25	Option Exercise	2.48	133,402	330,837	312,517	Mar 07 09:00 PM
Verdine Gregory L.	Director	Mar 05 '25	Option Exercise	2.48	133,000	329,840	179,155	Mar 07 09:00 PM
PAUL BOLNO	Officer	Mar 07 '25	Proposed Sale	9.57	169,025	1,618,228		Mar 07 05:10 PM
Vargeese Chandra	See Remarks	Mar 04 '25	Option Exercise	2.48	91,754	227,550	362,687	Mar 05 05:14 PM
Vargeese Chandra	See Remarks	Jan 23 '25	Option Exercise	2.48	46,000	114,080	233,933	Jan 24 05:30 PM
BOLNO PAUL	President and CEO	Nov 25 '24	Option Exercise	2.48	50,000	124,000	267,351	Nov 27 09:00 PM
BOLNO PAUL	President and CEO	Nov 25 '24	Sale	15.00	50,000	750,000	217,351	Nov 27 09:00 PM
PAUL BOLNO	Officer	Nov 25 '24	Proposed Sale	15.00	50,000	750,000		Nov 25 05:09 PM
BOLNO PAUL	President and CEO	Nov 15 '24	Sale	14.32	51,234	733,671	217,351	Nov 15 09:00 PM
PAUL BOLNO	Officer	Nov 15 '24	Proposed Sale	14.32	51,234	733,743		Nov 15 04:16 PM
Francis Chris	See Remarks	Nov 08 '24	Option Exercise	8.17	36,000	294,120	36,000	Nov 13 08:00 PM
Francis Chris	See Remarks	Nov 08 '24	Sale	16.00	36,000	576,000	0	Nov 13 08:00 PM
CHRISTOPHER FRANCIS	Officer	Nov 08 '24	Proposed Sale	16.00	36,000	576,000		Nov 08 04:14 PM
Francis Chris	See Remarks	Oct 16 '24	Option Exercise	2.88	129,122	371,410	65,625	Oct 18 08:00 PM
Francis Chris	See Remarks	Oct 16 '24	Sale	13.67	208,836	2,855,051	0	Oct 18 08:00 PM
BOLNO PAUL	President and CEO	Oct 16 '24	Sale	15.00	90,474	1,357,110	268,585	Oct 18 08:00 PM
CHRISTOPHER FRANCIS	Officer	Oct 16 '24	Proposed Sale	13.67	208,836	2,855,051		Oct 16 04:19 PM
PAUL BOLNO	Officer	Oct 16 '24	Proposed Sale	15.00	90,474	1,357,110		Oct 16 04:13 PM
Moran Kyle	Chief Financial Officer	Oct 11 '24	Option Exercise	2.48	25,000	62,000	44,777	Oct 11 08:00 PM
GSK plc	10% Owner	Sep 27 '24	Buy	8.00	2,791,930	22,335,440	16,775,691	Oct 01 05:54 PM
Moran Kyle	Chief Financial Officer	Sep 25 '24	Sale	9.00	17,146	154,314	19,777	Sep 27 08:00 PM
KYLE MORAN	Officer	Sep 25 '24	Proposed Sale	9.00	17,146	154,314		Sep 25 09:40 PM

PACB Pacific Biosciences of California Inc daily Stock Chart

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG VTI IWM VXF IWN IBB VTWO SCHA VHT

Index	RUT	P/E	-	EPS (ttm)	-2.27	Insider Own	11.96%	Shs Outstand	300.35M	Perf Week	-7.87%
Market Cap	351.43M	Forward P/E	-	EPS next Y	-0.51	Insider Trans	-0.09%	Shs Float	264.44M	Perf Month	-8.59%
Enterprise Value	735.61M	PEG	-	EPS next Q	-0.15	Inst Own	55.96%	Short Float	14.03%	Perf Quarter	-0.85%
Income	-525.16M	P/S	2.25	EPS this Y	-50.51%	Inst Trans	-18.75%	Short Ratio	4.70	Perf Half Y	-2.50%
Sales	156.11M	P/B	5.72	EPS next Y	69.72%	ROA	-44.98%	Short Interest	37.11M	Perf YTD	-36.07%
Book/sh	0.20	P/C	1.12	EPS next 5Y	28.08%	ROE	-189.52%	52W High	2.72 -56.99%	Perf Year	-32.76%
Cash/sh	1.05	P/FCF	-	EPS past 3/5Y	-21.38% -23.55%	ROIC	-69.10%	52W Low	0.85 37.47%	Perf 3Y	-80.03%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.67% 11.12%	Gross Margin	-215.73%	Volatility	6.38% 6.15%	Perf 5Y	-81.92%
Dividend TTM	-	EV/Sales	4.71	EPS Y/Y TTM	-19.34%	Oper. Margin	-364.72%	ATR (14)	0.09	Perf 10Y	-75.11%
Dividend Ex-Date	-	Quick Ratio	6.02	Sales Y/Y TTM	-17.35%	Profit Margin	-336.40%	RSI (14)	40.04	Recom	2.31
Dividend Gr. 3/5Y	- -	Current Ratio	6.92	EPS Q/Q	78.04%	SMA20	-9.02%	Beta	2.11	Target Price	2.00
Payout	-	Debt/Eq	11.37	Sales Q/Q	10.42%	SMA50	-15.08%	Rel Volume	1.20	Prev Close	1.26
Employees	575	LT Debt/Eq	11.36	Earnings	Aug 07 AMC	SMA200	-18.21%	Avg Volume	7.90M	Price	1.17
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.70% 8.61%	Trades		Volume	9,465,276	Change	-7.14%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Sep-12-25 06:15PM	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks) -7.14%
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
Sep-03-25 09:05AM	PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (GlobeNewswire)
Aug-22-25 02:25PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +9.52%
Aug-19-25 01:51PM	Cathie Woods ARK Innovation Sees Outflows, But Buys More Deere Stock Anyway (Barrons.com)
01:34AM	Loading…
Aug-14-25 01:34AM	The Top 5 Analyst Questions From PacBio's Q2 Earnings Call (StockStory)
Aug-13-25 03:01PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +5.79%
Aug-11-25 09:38AM	PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results (StockStory) -6.67%
Aug-08-25 12:21PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +7.14%
12:07PM	PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises (Zacks)
Aug-07-25 07:30PM	Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -8.70%
07:00PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:58PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press Finance)
05:07PM	PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars (StockStory)
04:05PM	PacBio Announces Second Quarter 2025 Financial Results (GlobeNewswire)
05:50PM	Loading…
Aug-06-25 05:50PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-05-25 11:18PM	PacBio (PACB) Q2 Earnings Report Preview: What To Look For (StockStory)
Aug-04-25 09:15AM	Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
09:05AM	Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models (GlobeNewswire)
Jul-31-25 12:03AM	3 Reasons to Avoid PACB and 1 Stock to Buy Instead (StockStory) -7.38%
Jul-29-25 06:15PM	Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -6.10%
03:30PM	PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know (StockStory)
09:35AM	Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings (Insider Monkey)
08:52AM	Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing (PR Newswire)
Jul-24-25 09:05AM	PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications (GlobeNewswire) -8.88%
Jul-23-25 01:11PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
09:05AM	PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio (GlobeNewswire)
Jul-22-25 04:05PM	QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels (Business Wire) +11.72%
Jul-21-25 04:05PM	PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire) +5.84%
06:15PM	Loading…
Jul-17-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks) -6.71%
Jul-10-25 06:15PM	Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Jul-09-25 11:57AM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jul-08-25 12:00PM	Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jul-03-25 09:08AM	Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue (Insider Monkey) +7.38%
Jun-30-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:50AM	The 5 Most Interesting Analyst Questions From PacBio's Q1 Earnings Call (StockStory)
Jun-13-25 11:30AM	Why Is Steris (STE) Down 1.8% Since Last Earnings Report? (Zacks)
Jun-12-25 06:15PM	Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)
Jun-10-25 06:41AM	PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds (StockStory)
Jun-05-25 12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 11:31PM	Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment (StockStory)
Jun-02-25 10:00AM	Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date (PR Newswire)
May-29-25 12:00PM	All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy (Zacks) -5.45%
May-28-25 09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) +20.85%
May-23-25 10:46AM	PacBio Stock Slips Despite New China Distribution Deal With Haorui (Zacks)
May-22-25 09:05AM	PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene (GlobeNewswire)
May-12-25 01:04PM	PACB Stock May Rise Following the Deal With Chulalongkorn University (Zacks)
10:56AM	PacBio Board Independent Investigation Concludes Allegations Unsubstantiated (GlobeNewswire)
May-09-25 12:00PM	PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates (Zacks) -6.67%
May-08-25 09:00PM	Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) +6.19%
05:30PM	Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:29PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	PacBio Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 12:38PM	Pacific Biosciences of California Q1 2025 Earnings Preview (Seeking Alpha)
11:08AM	Earnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 Result (GuruFocus.com)
May-05-25 09:05AM	First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand (GlobeNewswire)
Apr-29-25 06:15PM	Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Apr-28-25 09:05AM	PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry (GlobeNewswire)
09:01AM	1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar (StockStory)
Apr-23-25 06:15PM	Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know (Zacks)
Apr-22-25 09:05AM	Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa (GlobeNewswire)
Apr-09-25 02:38PM	PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know (StockStory) +20.83%
09:05AM	PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million (GlobeNewswire)
Apr-04-25 07:45PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +7.32%
Mar-27-25 09:05AM	Jim Gibson to join PacBio as Chief Financial Officer (GlobeNewswire)
Mar-20-25 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
01:05PM	Here's Why You Should Retain PacBio Stock in Your Portfolio Now (Zacks)
Mar-18-25 06:15PM	Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading? (Insider Monkey)
05:08AM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
Mar-17-25 09:05AM	Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes (GlobeNewswire)
05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-14-25 06:15PM	Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Mar-11-25 09:01AM	1 Healthcare Stock to Target This Week and 2 to Turn Down (StockStory) -5.76%
Feb-19-25 04:05PM	PacBio to Participate in TD Cowen's 45th Annual Health Care Conference (GlobeNewswire) -5.35% -7.34%
Feb-15-25 11:02AM	PacBio should return to growth over time, says Canaccord (TipRanks)
Feb-14-25 11:09PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +25.00%
02:21AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Feb-13-25 06:00PM	Compared to Estimates, Pacific Biosciences (PACB) Q4 Earnings: A Look at Key Metrics (Zacks) +8.82%
05:20PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:13PM	PacBio (NASDAQ:PACB) Misses Q4 Sales Targets (StockStory)
04:28PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire)
Feb-12-25 08:03AM	PacBio (PACB) Q4 Earnings Report Preview: What To Look For (StockStory)
07:42AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-04-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why (Zacks) +13.89%
Feb-03-25 09:05AM	PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service (GlobeNewswire) -5.19%
Jan-30-25 04:05PM	PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025 (GlobeNewswire)
09:05AM	PacBio Announces Appointment of Chris Smith to Board of Directors (GlobeNewswire)
Jan-29-25 09:05AM	PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics (GlobeNewswire)
Jan-27-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -1.18%: What You Should Know (Zacks)
Jan-24-25 09:16AM	PacBio announces GIFS at USask as first Revio PacBio CSP in Canada (TipRanks)
Jan-23-25 09:05AM	PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider (GlobeNewswire) -8.84%
Jan-14-25 09:05AM	PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics (GlobeNewswire) -7.96%
09:00AM	PacBio Announces Preliminary Fourth Quarter and Full Year Revenue (GlobeNewswire)
Jan-10-25 06:05AM	PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing (GlobeNewswire)
Jan-08-25 09:05AM	PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets (GlobeNewswire)
Jan-07-25 06:15PM	Why the Market Dipped But Pacific Biosciences of California (PACB) Gained Today (Zacks)
11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-02-25 04:05PM	PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +10.56%

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM
Van Oene Mark	See Remarks	Jan 10 '25	Sale	2.03	34,405	69,980	1,597,454	Jan 10 04:54 PM
MARK VAN OENE	Officer	Jan 10 '25	Proposed Sale	2.03	34,405	69,980		Jan 10 04:23 PM
Kim Susan G.	See Remarks	Sep 30 '24	Sale	1.72	19,782	34,065	695,654	Oct 02 04:13 PM
SUSAN KIM	Officer	Sep 30 '24	Proposed Sale	1.72	19,782	34,061		Sep 30 04:03 PM
HENRY CHRISTIAN O	See Remarks	Sep 16 '24	Sale	1.75	98,907	172,692	2,497,763	Sep 17 04:11 PM
CHRISTIAN HENRY	Officer	Sep 16 '24	Proposed Sale	1.75	98,907	172,741		Sep 16 05:40 PM

DNA

Ginkgo Bioworks Holdings Inc

WVE

Wave Life Sciences Ltd

PACB

Pacific Biosciences of California Inc

Upgrade your FINVIZ experience